"Nowadays Omar, you have to create a buzz around yourself. You have to get people's attention and do most of the leg work yourself before a major label (distributor) will even look at you, or invest in you."When he said this, I began thinking about how difficult it was to get funding now in Med-tech, and especially how some of the rugged veterans of med-tech have spoken openly about how meetings with venture capital firms have evolved. In fact during one conference, a panelist described showing off a drawing of a device on a napkin to a VC firm and eventually getting support for the technology. Try doing that today he joked. But the fact of the matter is, is that funding is trickier to get than it was in the past. Series A financings are really tough to secure to get, as VC firms are no longer looking to get in on the ground floor for some of these devices. VC firms want tried and true proven evidence. It's even better if the company has approval for the device. One could say this almost defeats the purpose and could possibly hinder innovation.